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Abstract 
Background: Cerebral malaria is one of the most severe complications of Plasmodium falciparum infection and 
occurs mostly in young African children. This syndrome results from a combination of high levels of parasitaemia and 
inflammation. Although parasite sequestration in the brain is a feature of the human syndrome, sequestering strains 
do not uniformly cause severe malaria, suggesting interplay with other factors. Host genetic factors such as muta-
tions in the promoters of the cytokines IL-10 and TNF are also clearly linked to severe disease. Plasmodium chabaudi, 
a rodent malaria parasite, leads to mild illness in wildtype animals. However, IL-10−/− mice respond to parasite with 
increased levels of pro-inflammatory cytokines IFN-γ and TNF, leading to lethal disease in the absence of sequestra-
tion in the brain. These mice also exhibit cerebral symptoms including gross cerebral oedema and haemorrhage, 
allowing study of these critical features of disease without the influence of sequestration.
Methods: The neurological consequences of P. chabaudi infection were investigated by performing a general behav-
ioural screen (SHIRPA). The immune cell populations found in the brain during infection were also analysed using flow 
cytometry and confocal microscopy.
Results: IL-10−/− mice suffer significant declines in behavioural and physical capacities during infection compared 
to wildtype. In addition, grip strength and pain sensitivity were affected, suggestive of neurological involvement. 
Several immune cell populations were identified in the perfused brain on day 7 post-infection, suggesting that they 
are tightly adherent to the vascular endothelium, or potentially located within the brain parenchyma. There was an 
increase in both inflammatory monocyte and resident macrophage (CD11bhi, CD45+, MHCII+, Ly6C+/−) numbers in 
IL-10−/− compared to wildtype animals. In addition, the activation state of all monocytes and microglia (CD11bint, 
CD45−, MHC-II+) were increased. T cells making IFN-γ were also identified in the brain, but were localized within the 
vasculature, and not the parenchyma.
Conclusions: These studies demonstrate exacerbated neuroinflammation concurrent with development of behav-
ioural symptoms in P. chabaudi infection of IL-10−/− animals.
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Background
With 214 million new cases and 438,000 estimated deaths 
in 2015, malaria remains one of the highest burdens in 
preventable and treatable infectious diseases worldwide 
[1]. Effective anti-malarial drugs often result in cure. 
However, as many as 10  % of Plasmodium falciparum 
infections worldwide result in severe malaria disease, 
including severe anaemia, pregnancy-associated malaria 
and cerebral malaria (CM) [2, 3]. CM correlates with high 
levels of parasitaemia, inflammation, and severe cerebral 
oedema [3]. There is little evidence that specific strains of 
P. falciparum are linked to this syndrome, although par-
asite adhesion in the brain and retina is associated with 
death [4]. On the other hand, host genetic factors, such 
as mutations in the promoters of the cytokines IL-10 and 
tumour necrosis factor (TNF), have been correlated with 
severe disease [5, 6]. Adding to the complex aetiology of 
CM, inflammation also promotes parasite sequestration, 
as demonstrated in murine models of experimental CM 
[2]. As a result, it is possible that inflammation is the pri-
mary precipitating cause of P. falciparum sequestration 
in the human brain and other organs.
Plasmodium chabaudi, a rodent malaria species, leads 
to uncomplicated disease in wildtype (WT) animals. 
However, in IL-10-deficient (IL-10−/−) mice, P. chabaudi 
infection leads to lethal disease characterized by cerebral 
pathology, including gross cerebral oedema and haemor-
rhage [7], in the absence of cerebral sequestration [8]. In 
P. chabaudi, sequestration has been documented in sev-
eral organs, including liver and lungs, but adherent para-
site is not readily detectable in the brain vasculature [8, 
9]. On the other hand, there is a strong spike of systemic, 
pro-inflammatory, TNF at the peak of infection that has 
been shown to cause the lethal pathology in this model 
[10]. As such, it is clear that inflammatory cytokines can 
promote, and anti-inflammatory cytokines protect from, 
malaria-related pathology in murine models [11–13]. 
In humans, a strong balance of the anti-inflammatory 
cytokine IL-10 with TNF is also known to be critical for 
control of parasitaemia and pathology [14].
Histopathological studies from fatal CM cases have 
provided insight into the pathologic events that corre-
late with fatal disease [15–17]. Recent striking studies 
linked evidence of severe cerebral oedema with death 
[3]. Cytokines such as TNF can cause vascular leakage 
and oedema; however, the causal mechanisms leading 
to blood–brain barrier breakdown and brain swelling 
in human CM cases are not clear. While sequestra-
tion is cited as a cause of vascular blockage and oedema 
[18], this has not been sufficiently demonstrated to date. 
Fortunately, animal models have been developed that 
share significant similarities to human cerebral malaria. 
In Plasmodium berghei ANKA-induced experimental 
cerebral malaria (ECM) infection, pathogenic mononu-
clear cells accumulate in cerebral blood vessels as a result 
of inflammatory TNF secretion and the upregulation 
of chemokine receptors like C-X chemokine receptor 
3 (CXCR3) on T cells [19] and cell-adhesion molecules 
such as intercellular adhesion molecule-1 (ICAM-1) on 
the vascular endothelium [20]. Furthermore, cytotoxic 
CD8+ T cell recruitment, occurring downstream of IFN-
γ, can directly damage microvascular endothelial cells 
and contribute to oedema [21–24].
In this study, the P. chabaudi murine model of malaria 
in IL-10−/− mice was used. These animals exhibit a severe 
disease phenotype [25, 26] including signs of neurologi-
cal involvement [7]. Previous studies in the Langhorne 
laboratory have shown severe brain oedema, as well as 
micro- and macro-haemorrhages [7]. However, there is 
no evidence of significant parasite sequestration in the 
brain [8, 9]. CD4+ IFN-γ+ T cells are the primary source 
of IL-10 in P. chabaudi infection [27], and neutralization 
of TNF ameliorates the severe phenotype, while TGF-β 
antibodies exacerbates disease [10]. This model provides 
an opportunity to investigate the effect of inflammatory 
cytokines, as separate from the effect of parasite seques-
tration in the brain, on neurological damage during 
malaria infection.
Neuroinflammation and behavioural changes have 
not been studied in the lethal course of disease in P. 
chabaudi-infected IL-10−/− animals. Furthermore, 
the type and location of immune cells in the brain are 
unknown in this model. Therefore, using the SHIRPA 
behavioural screen, general health, neurological reflexes, 
and baseline behaviour were assayed. Multiple defi-
ciencies in these measures were observed in infected 
IL-10−/− mice compared with even the most moribund 
WT animals. A significant population of monocytes was 
found in the brains of P. chabaudi-infected IL-10−/− mice 
by flow cytometry. T cells were also found in the brain, 
although not at significantly higher levels than WT ani-
mals. Interestingly, the infiltration of T cells was localized 
primarily to blood vessels and not the brain parenchyma. 
This study supports the role of cellular inflammation in 
promoting lethal malarial pathology and behavioural 
changes in mice infected with P. chabaudi.
Methods
Mice
C57Bl/6 (WT) and B6.129P2-Il10tm1Cgn/J (IL-10−/−) ani-
mals (The Jackson Laboratory, Bar Harbor, ME) were 
bred in The University of Texas Medical Branch (UTMB) 
animal care facility. Experimental animals were between 
6 and 12  weeks of age at the time of infection. All ani-
mals were kept in specific-pathogen free housing with 
ad  libitum access to food and water. General health, 
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neurological, and behavioural analyses were performed 
on 16 IL-10−/− and 16 wildtype mice (female only) in 
UTMB’s Rodent in Vivo Assessment (RIVA) core facil-
ity (directed by Dr. Kelly Dineley) housed within the 
Center for Addiction Research (directed by Dr. Kathryn 
Cunningham).
Parasite and infection
Frozen stocks of Plasmodium chabaudi chabaudi (AS)-
infected RBCs (iRBCs) (Jean Langhorne, Francis Crick 
Institute, London, UK) stored at −80 °C were thawed and 
injected intraperitoneally (i.p.) into C57Bl/6 mice. Para-
sitaemia was assessed by preparing thin blood smears 
stained with Diff-Quik (Siemens Healthcare Diagnos-
tics, Newark, DE) and counted using a light microscope. 
Parasitized blood was diluted in Krebs glucose, and nor-
mal saline to deliver 105 iRBCs in 200 μL i.p. Thin blood 
smears were collected at regular intervals to monitor for 
peripheral parasitaemia.
Animal body temperature and weight
Internal body temperature measurements were deter-
mined by subcutaneous implantation of IPTT-300 tem-
perature transponders and read using a DAS-6007 reader 
system (BMDS, Seaford, DE). Animal weights were meas-
ured using an OHAUS CS 200 portable balance (OHAUS, 
Parsippany, NJ).
Behavioural studies
Beginning on day three post-infection, throughout the 
peak of parasitaemia (days 9–11), and up to day 14, all 
surviving animals were assessed using a modified Smith-
Kline Beecham, Harwell, Imperial College, Royal London 
Hospital, phenotype assessment (SHIRPA) protocol [28]. 
This comprehensive behavioural assessment involves a 
battery of 33 semi-quantitative tests for general health 
and sensory function, baseline behaviours and neurologi-
cal reflexes. Higher scores are given for measures show-
ing higher functional ability. The procedures were carried 
out in an open testing environment away from the home 
cage, and took 15–20 min per animal daily.
Initially, observation of undisturbed behaviour was 
conducted with the mouse in an open-bottomed viewing 
jar placed on top of a metal grid suspended above a piece 
of white paper for 3  min, during which Body Position, 
Spontaneous Activity, Respiration Rate, and Tremor were 
assessed. Body Position scores ranged from 0 (completely 
flat) to 5 (repeated vertical leaping). Spontaneous Activ-
ity scores ranged from 0 (none) to 4 (rapid/dart move-
ment). Respiration Rate scores ranged from 0 (irregular) 
to 3 (hyperventilation). Tremor scores ranged from 0 
(important) to 2 (none). At the end of the observation 
period, the number of fecal pellets and urinary stains 
accumulated on the paper was recorded. Transfer arousal 
is measured by transferring the animal in the jar quickly 
to a gridded arena (3 × 5 grid) from ~6 to 8 inches in the 
air. The immediate reaction is recorded with scores rang-
ing from 0 (no movement) to 6 [19]. Locomotor activity is 
the number of squares entered by all four feet in 30 s after 
transfer. Palpebral closure is scored from 0 (eyes closed) 
to 2 (eyes wide open), and piloerection is 0 (present) or 
1 (absent). Gait is observed as the animal traverses the 
arena and is scored from 0 (incapacity) to 3 (normal). 
Pelvic elevation notes the height the animal’s pelvis as 
it moves, and is scored from 0 (markedly flattened) to 
3 (elevated). Similarly, tail elevation scores range from 
0 (dragging) to 2 (elevated). Touch escape measures the 
reaction to a finger stroke, and is scored from 0 (no 
response) to 3 (escape response to approach). Positional 
passivity records the animal’s response to sequential 
handling, with scores ranging from 0 (no struggle) to 4 
(struggles when held by tail). Trunk curl is recorded as 
either 0 (absent) or 1 (present) and limb grasping is either 
0 (absent) or 1 (present), while holding the animal by 
the tail. As the animal is lowered back down to the wire 
grid, visual placing (how early the animal reaches out for 
the grid) is scored from 0 (none) to 4 (early extension at 
25 mm). As the animal grips the grid, a gentle horizon-
tal pressure is applied to assess qualitative grip strength, 
scored from 0 (none) to 4 (unusually strong). Body tone is 
assessed by compressing the sides of the animal between 
the thumb and index finger, and scored from 0 (flaccid) 
to 2 (extreme resistance). Pinna reflex is observed by ear 
retraction to the tip of a fine cotton swab, recorded as 0 
(none) to 2 (repetitive flick). Corneal reflex is measured 
by lightly touching the cornea of the animal with a cotton 
swab and scored from 0 (none) to 2 (multiple eye blinks). 
Toe pinch is assessed by gentle compression of a hind foot 
digit with fine forceps to observe the response, scored 
from 0 (none) to 4 (repeated extension and flexion). Wire 
maneuver is assessed by measuring the length of grasp on 
an inverted wire grid, scored from 0 (falls immediately) 
to 4 (active grip with hind legs). Skin color 0 (blanched) 
to 2 (flushed); heart rate 0 (slow) to 2 (fast); limb tone as 
measured by resistance to gentle fingertip pressure of the 
plantar surface of the hind paw, scored 0 (no resistance) 
to 4 (extreme resistance); abdominal tone by palpation of 
the abdomen, scored 0 (flaccid) to 2 (extreme resistance); 
lacrimation as 0 (present) or 1 (absent). A small dowel 
is inserted between the teeth at the side of the animal’s 
mouth to measure salivation, recorded as 0 (wet zone 
entire sub-maxillary area) to 2 (none), and provoked bit-
ing, recorded as 0 (present) or 1 (absent). Righting reflex 
is scored from an upside-down position near the surface 
and observing the responding effort to upright itself upon 
release, scored from 0 (fails to right) to 3 (lands on feet). 
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Contact righting reflex is assessed by placing the animal 
inside a plastic restrainer tube and inverting it to assess 
its ability to sense its position and correct, scored as 0 
(absent) or 1 (present). Throughout this entire battery of 
tests, vocalization, urination, and general fear, irritabil-
ity, or aggression were recorded as either being 0 (pre-
sent) or 1 (absent). For analysis, SHIRPA data was pooled 
from infected IL-10−/− mice exhibiting fatal symptoms 
early during the acute phase of infection (<12 days post-
inoculation) and synchronized to the time of death of the 
individual mouse. Synchronized IL-10−/− SHIRPA scores 
were compared to the peak of infection for C57Bl/6J con-
trol animals (day 10 post-inoculation).
Forelimb grip strength
Quantitative forelimb grip strength was measured using a 
Chatillon DFIS-2 digital force gauge (Ametek, Largo, FL) 
measuring maximal grams of resistance by restraining 
the animal at the base of the tail and allowing it to grasp 
the tension bar whilst pulling back gently until the animal 
released its grip. Resistance was calculated in real-time 
and the maximal resistance achieved by each mouse was 
averaged. Animals were subjected to three trials (with at 
least 10 min of rest between each trial).
Tail flick analgesia
To test for nociceptive pain sensitivity, animals were 
placed on a tail flick analgesia meter (Columbus Instru-
ments, Columbus, OH) and gently restrained. Latency to 
tail flick was recorded as the time (in seconds) required 
for the mouse to move its tail out of the path of a heat 
source. Animals were subjected to three trials with no 
less than 20 min between trials.
Flow cytometry
Mice infected with Plasmodium chabaudi were anes-
thetized with inhaled isoflurane (0.25–3  %, to effect) 
or ketamine/dexmedetomidine cocktail (60–75  mg/
kg  K, 0.5–1.0  mg/kg D) i.p. and perfused with 20  mLs 
PBS via cardiac puncture. Single-cell suspensions from 
brains were made in PBS by pressing through a 70  µm 
cell strainer, enriched within a 30/70  % Percoll inter-
face (Sigma-Aldrich, St. Louis, MO), and stained in PBS 
supplemented with 2  % FBS (Sigma-Aldrich) and 0.1  % 
sodium azide with anti-CD16/32 (2.4G2) supernatant 
(BioXCell). This was followed by combinations of FITC, 
PE, PerCP-Cy5.5, PE/cyanine 7 (Cy7), PE/Cy5, (allophy-
cocyanin)-, or allophycocyanin/eflour780–conjugated 
Abs (all from eBioscience); CD4-Brilliant Violet 785 (Bio-
Legend, San Diego, CA); Ly5.2 PE, Ly-6C FITC, TNF-PE/
Cy7 (all from eBioscience), and CD11b-Biotin, followed 
by Streptavidin-PE/Cy5. Cells were collected on a LSRII 
Fortessa using FACSDiva software (BD Biosciences, San 
Jose, CA) and analysed in FlowJo (version 9.7, TreeStar, 
Ashland, OR). Cells were analysed within 1  h of stain-
ing. For intracellular staining of IFNγ and TNF, cells were 
stimulated for 3 h with PMA/Ionomycin and Brefeldin A 
for 2 additional hours before fixation in 2 % paraformal-
dehyde (Sigma-Aldrich) and permeabilization using BD 
Perm/Wash buffer. Subsequently, cells were incubated 
with IFNγ-Brilliant Violet 605 (BioLegend) and TNF PE/
Cy7 (eBioscience) for 40 min at 4  °C and washed. Com-
pensation was performed in FlowJo using single-stained 
splenocytes (using CD4 in all colors). For presenta-
tion, data from three to four mice were concatenated to 
achieve sufficient cell numbers, from which averages and 
SEM were calculated.
Confocal microscopy
Infected IL-10−/− and WT animals were injected with 
2 × 106 Cell Trace Violet+ (CTV+) CD4 T cells i.p. 3.5 h 
before sacrifice, and 40ug of DyLight488 labelled Lyco-
persicon esculentum (Tomato) Lectin i.v. 20  min before 
sacrifice without intracardiac perfusion. After 48  h of 
post-fixation in 4 % paraformaldehyde and 48 h of cryo-
protection in 30  % sucrose, 30  μm frozen sagittal sec-
tions of mouse brains were made using Tissue Freezing 
Medium (Triangle Biomedical Sciences, Durham, NC), 
mounted on glass slides with fluorescent mounting 
medium (DAKO, Carpinteria, CA), and cover slipped. 
Confocal images were acquired on a Fluoview 1000MPE 
system configured with an upright BX61 microscope 
(Olympus, Center Valley, PA). Images were analysed 
using Olympus Fluoview FV1000-ASW 2.0 Viewer.
Statistics
Where indicated, experiments were analysed by one-way 
ANOVA, followed by Student’s t test or Wilcoxon rank-
sum test for nonparametric data, in Prism (GraphPad, 
La Jolla, CA) and SigmaPlot 12.0 (Systat Software, San 
Jose, CA): *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. Error bars 
represent ± SEM.
Results
IL‑10−/− animals infected with P. chabaudi exhibit deficits 
in behavioural tests prior to death
Infected IL-10−/− mice suffered a more severe course of 
disease with decreased survival (females: 6/39, 15.4  %; 
males: 9/20, 45.0  %; Additional file  1) and significant 
weight and temperature loss, despite comparable para-
sitaemia to WT animals (Additional file  1). The major-
ity of IL-10−/− animals succumbed between days 7 and 
11 post-infection. This is comparable to previous studies 
in P. chabaudi, although mortality is increased [25, 26]. 
While severe anaemia is an important cause of death in 
P. chabaudi infection of several strains of mice [29, 30], 
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anaemia peaks in both IL-10−/− and WT mice at day 10 
post-infection [25], and not during the time frame when 
most IL-10−/− animals are succumbing to infection (days 
7–9 post-infection, Additional file 1). Furthermore, anae-
mia is not an accurate predictor of mortality [10], nor 
is it correlated with percent parasitaemia in this model 
[31]. In order to determine the behavioural phenotype 
of IL-10−/− mice infected with P. chabaudi, IL-10−/− and 
WT mice were infected with 105 P. chabaudi-infected 
red blood cells (iRBCs), and a comprehensive animal 
health and behaviour assessment was performed daily. 
The SHIRPA, a rigorous and semi-quantitative battery 
of tests, has revealed significant deficits in animals with 
P. berghei ANKA-induced experimental cerebral malaria 
[32]. During the acute phase of infection (5–14  days 
post-infection), IL-10−/− mice demonstrated significant 
deficiencies in many behavioural tests when compared 
to infection-matched WT mice. However, more results 
of the SHIRPA assessment became significant when ana-
lysed at time points closer to death, even when compared 
to WT mice at their most severe state (10  days post-
infection). This analysis is shown in Table 1. Deficiencies 
in each SHIRPA functional domain in infected IL-10−/− 
mice were found, suggesting that malaria infection affects 
a broad array of neurological functions.
Locomotor activity is measured as the number of 
squares on a grid traversed by mice exploring a new 
environment, and has been used as a surrogate measure 
of non-specific sickness behaviour in P. berghei ANKA 
infection [33]. This activity decreased similarly between 
groups, until day 7 post-infection, from which time on 
there was a non-significant trend for surviving IL-10−/− 
animals to move less (Fig.  1a). A decrease in spontane-
ous activity was specific to the IL-10−/− group, and was 
reduced beginning 8  days post-infection (Fig.  1b). Fur-
thermore, forelimb grip strength and nociceptive pain 
sensitivity, measures of motor and pain-sensing neural 
activity, in infected IL-10−/− mice became significantly 
different from WT mice on days 8 and 14 post-infection, 
respectively (Figs.  1c, d). In summary, IL-10−/− mice 
infected with P. chabaudi develop behavioural and func-
tional deficiencies across all categories of the SHIRPA 
assessment, suggesting damage across several brain 
areas, including the circuitry underlying locomotor activ-
ity, strength, and analgesia.
IL‑10−/− animals show increased CD11b+ immune cells 
and increased microglia activation in the brain during P. 
chabaudi infection
In order to identify the cellular populations present in 
the brains of IL-10−/− mice infected with P. chabaudi, 
single-cell suspensions from perfused brains were pre-
pared for flow cytometry. During the acute phase of 
infection (7–9 days post-infection), lymphocytes (CD45hi, 
CD11b−), monocytes/macrophages (CD45hi, CD11b+), 
microglia (CD45int, CD11b+), and non-hematopoietic 
cells (CD45−, CD11b−) were detected. All infected ani-
mals had a significant increase in the fraction of cells in 
the monocyte/macrophage gate, with the IL-10−/− group 
increasing the most (Fig.  2a). Within the monocyte/
macrophage gate, migrating “inflammatory monocytes” 
(CD11b+, Ly6C+, MHC-II+) were distinguished from the 
rest of the macrophage population. Migratory monocytes 
were increased in the brains of infected IL-10−/− animals 
(Fig.  2b). CD11b+Ly6C−MHC-II+ macrophages, which 
include resident and some migratory macrophages, were 
also increased in both infected WT and IL-10−/− groups. 
However, the numbers of Ly6C− macrophages in brains 
of infected IL-10−/− animals were greater compared to 
infection-matched WT animals and uninfected con-
trols. Furthermore, MHC-II expression was found to be 
upregulated on the entire CD45hiCD11b+ monocyte/
macrophage population compared to WT infected and 
uninfected controls, suggesting activation (Fig.  2c). In 
addition, microglia (CD45int, CD11b+) in the brains of 
infected IL-10−/− mice also showed increased expression 
of MHC-II (Fig. 3). An increase in peripheral immune cell 
populations and the activation state of resident microglia 
suggests cellular infiltration in the brains of IL-10−/− 
mice infected with P. chabaudi.
Mice have IFN‑γ‑producing T cells in the brain during P. 
chabaudi infection
As T cells have been implicated in the pathogenesis of 
ECM [34–36], and the death of P. chabaudi-infected 
IL-10−/− mice [27], infiltrating CD4+ and CD8+ T cells 
were specifically stained within the lymphocyte gate 
(CD45hi, CD11b−, Thy1 (CD90)+) (Fig.  4a). Staining B 
cells with CD19 identified a minority of animals with B 
cells in the brain as well (data not shown). Some IL-10−/− 
animals had an increased number of CD4+ and CD8+ T 
cells in the brain, however it was not found to be signifi-
cantly different from WT or uninfected controls (Fig. 4b). 
Almost all of the T cells present within the brains of 
infected WT and IL-10−/− mice expressed IFN-γ. Impor-
tantly, CD4+ T cells in IL-10−/− mice expressed much 
higher levels of IFN-γ per cell than CD8+ T cells (Fig. 4c). 
As the brains were perfused, these cells could be adher-
ent to the vascular endothelium or infiltrating the brain 
parenchyma. Therefore, it is important to define their 
localization to determine the function that these cells 
may play in the pathogenesis of severe malaria.
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Table 1 Plasmodium chabaudi-infected IL-10−/− mice show impaired performance in the SHIRPA assessment (Categories 
adapted from [32])
Compiled from two independent experiments, female IL-10−/− mice (n = 11) and C57Bl/6 J mice (n = 16) were inoculated with 105 Pcc-iRBCs i.p. and followed for 
10–14 days during the acute phase of infection in which the SHIRPA comprehensive behavioral assessment was performed daily. SHIRPA data was pooled from 
infected IL-10−/− mice exhibiting fatal symptoms early during the acute phase of infection (<12 days post-inoculation) and synchronized to the time of death of the 
individual mouse. Synchronized IL-10−/− SHIRPA scores were compared to the peak of infection for C57Bl/6J control animals (day 10 post-inoculation). Data shown are 
median (lower/upper quartile) or mean (± SD) where appropriate. Statistical significance determined by Rank Sum Test or Student’s t test (p < 0.05). Significant values 
are starred and displayed in italic font
Day 10 IL‑10−/− vs. C57BL/6J
C57BL/6J <120 h <96 h <72 h <48 h <24 h
n = 16 n = 4 p n = 6 P n = 5 p n = 5 p n = 8 p
Weight 17.8 (1.6) 18.2 (2.7) NS 17.4 (1.9) NS 16.8 (3.1) NS 16.4 (2.3) NS 14.7 (1.9) <0.001*
Reflex/sensory function
 Visual placing 4 (4/4) 3.5 (3/4) NS 3 (3/4) 0.015* 3 (3/4) 0.039* 3 (3/3.5) 0.005* 3 (3/4) 0.006*
 Pinna reflex 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS
 Corneal reflex 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS
 Toe pinch 4 (4/4) 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS
 Righting reflex 3 (3/3) 3 (3/3) NS 3 (3/3) NS 3 (3/3) NS 3 (2.5/3) NS 3 (1/3) 0.018*
 Cont. right. reflex 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS
Neuropsychiatric state
 Spont. activity 2 (2/2) 2 (2/2) NS 2 (2/2) NS 2 (1/2) 0.012* 1 (1/2) 0.001* 1 (1/1.5) <0.001*
 Transfer arousal 5 (5/5) 5 (4.25/5) NS 5 (4/5) NS 5 (4.5/5) NS 3 (2.5/5) 0.017* 2 (2/4.5) <0.001*
 Touch escape 2 (2/2) 2 (2/2) NS 2 (2/2) NS 2 (1.5/2) NS 2 (2/2) NS 2 (1/2) 0.005*
 Posit. passivity 4 (4/4) 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS
 Provoked biting 0 (0/0) 0 (0/0) NS 0 (0/0) NS 0 (0/0) NS 0 (0/0.5) NS 1 (0/1) 0.001*
 Fear 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 0 (0/1) 0.001* 0 (0/1) <0.001*
 Irritability 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (0.5/1) NS
 Aggression 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS
 Vocalization 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (0/1) NS 0 (0/0.5) 0.002*
Motor behavior
 Body position 4 (3/4) 4 (4/4) NS 4 (4/4) NS 3 (3/3.5) NS 3 (3/3.5) NS 3 (3/3.5) 0.043*
 Tremor 2 (2/2) 2 (2/2) NS 2 (2/2) NS 2 (2/2) NS 2 (1/2) 0.012* 2 (1/2) 0.005*
 Locom. activity 6.2 (4.9) 8.8 (5.4) NS 14.3 (8.2) 0.009* 8.6 (4.8) NS 4.2 (2.8) NS 3.7 (1.9) NS
 Pelvic elevation 2 (2/2) 2 (2/2) NS 2 (2/2) NS 2 (2/2) NS 2 (2/2) NS 2 (1.5/2) NS
 Gait 3 (3/3) 3 (3/3) NS 3 (3/3) NS 3 (3/3) NS 3 (2/3) 0.012* 3 (1.5/3) 0.005*
 Tail elevation 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (0/1) 0.018*
 Trunk curl 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS
 Limb grasping 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS
 Wire maneuver 4 (4/4) 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (2/4) 0.018*
 Negative geotaxis 4 (4/4) 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (4/4) NS 4 (0/4) 0.018*
Autonomous function
 Resp. rate 3 (2/3) 2 (2/2) 0.034* 2 (2/2) 0.012* 3 (2/3) NS 2 (2/3) NS 2 (2/3) NS
 Feces 1.3 (1.6) 2.0 (0.8) NS 1.0 (1.5) NS 0.2 (0.4) NS 0.4 (0.5) NS 0.4 (1.0) NS
 Urine 0 (0/0) 0 (0/0) NS 0 (0/0) NS 0 (0/0) NS 0 (0/0) NS 0 (0/0) NS
 Palpebral closure 2 (2/2) 2 (2/2) NS 2 (2/2) NS 2 (1.5/2) NS 2 (1/2) 0.012* 2 (1/2) 0.005*
 Piloerection 0 (0/0.75) 1 (1/1) 0.009* 1 (1/1) 0.002* 1 (0/1) NS 0 (0/1) NS 0 (0/1) NS
 Skin color 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (0/1) NS
 Heart rate 2 (1.25/2) 1 (1/1) 0.009* 1 (1/1) 0.002* 1 (1/2) NS 1 (1/1.5) 0.035* 1 (1/1) 0.002*
 Lacrimation 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (0.5/1) NS 1 (0/1) 0.012* 1 (0/1) 0.005*
 Salivation 1 (0/2) 0 (0/0.75) NS 0.5 (0/1) NS 1 (0/2) NS 1 (0/2) NS 2 (2/2) 0.015*
 Temperature 36.4 (0.9) 38.5 (0.2) 0.019* 38.7 (0.3) 0.011* 37.9 (0.3) 0.031* 35.5 (3.1) NS 33.4 (2.9) 0.021*
Muscle tone and strength
 Grip strength 3 (3/3) 3 (3/3) NS 3 (3/3) NS 3 (3/3) NS 3 (2.5/3) NS 2 (1.5/3) <0.001*
 Body tone 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (0.5/1) NS
 Limb tone 2 (2/2) 2 (2/2.75) NS 2 (2/3) NS 2 (2/3) NS 2 (2/3) NS 2 (2/2) NS
 Abdominal tone 1 (1/1) 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS 1 (1/1) NS
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CD4+ T cells exhibit intravascular localization in IL‑10−/− 
animals infected with Plasmodium chabaudi
To investigate the localization of potentially pathogenic 
CD4+ T cells relative to the vasculature, CellTrace Vio-
let+ (CTV+) polyclonal CD4+ T cells were transferred 
from infection-matched (day 7 post-infection) IL-10−/− 
donors, and injected with Tomato lectin, which stains 
glycoproteins localized to the vascular endothelium. 
Adoptively transferred cells were visualized by confo-
cal microscopy. The vast majority of T cells remained 
within the brain vasculature, as opposed to invading the 
parenchyma (Fig. 5). Upon closer inspection, the T cells 
that appeared to localize to the parenchyma displayed 
several anomalies (multiple fluorescent staining, out of 
focus) that decrease their likelihood of representing true 
transendothelial migration. Thicker brain sections were 
also observed with multiphoton microscopy, confirming 
localization of CD4+ T cells in the vasculature (data not 
shown). In conclusion, CD4+ T cells that are responsi-
ble for lethal pathology in P. chabaudi-infected IL-10−/− 
mice do not infiltrate the parenchyma, but remain 
within the blood vessels supplying the brain.
Discussion
In this study, behavioural and immunological out-
comes of P. chabaudi infection in IL-10−/− animals were 
assessed. The goal was to identify the cellular immune 
populations associated with the neurological syndrome 
and the fatal phenotype [10, 25, 26]. While brain pathol-
ogy has been well-documented in this model [10], behav-
ioural assessments have not been performed to confirm 
that infection had severe effects on general health, neu-
rological reflexes, and baseline behaviours in IL-10−/− 
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Fig. 1 IL-10−/− mice exhibit impaired general health, neurological reflexes and baseline behavioural measures during Plasmodium chabaudi 
infection. As part of the comprehensive SHIRPA behavioural assessment in infection-matched IL-10−/− (KO) and C57Bl/6J (WT) control mice, (a) 
locomotor activity was measured by allowing the mice to explore a novel grid enclosure for 30 s. The number of squares traversed by all four feet 
was measured within the allotted time. b Spontaneous activity was measured by observing the mouse within an enclosed environment for 2 min. 
Scores ranged from 0 (no activity, resting) to 4 (extremely vigorous, rapid/dart movement), with the baseline score being 2 (vigorous scratch, 
groom, moderate movement). c Animal forelimb grip strength was tested using a digital force-gauging apparatus measuring maximal grams of 
resistance. Animals were subjected to 3 trials (with at least 10 min of rest between each trial). d Nociceptive pain sensitivity was tested by a tail 
flick analgesia apparatus to measure the latency of tail removal from a nociceptive stimulus. Student’s t test (a, c, d) or Rank sum test (b) *p < 0.05, 
**p < 0.01, ***p < 0.001. Data points and error bars represent mean values and ± SEM, respectively
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populations found in the brain also had not been investi-
gated by flow cytometry or confocal microscopy.
Behavioural studies in the P. berghei ANKA model 
have established a correlation between the deterioration 
in motor skills and neuromuscular function with histo-
pathological changes associated with ECM [32, 33, 37]. 
Mice infected with P. berghei ANKA and evaluated with 
the SHIRPA exam showed early indications of neurologi-
cal consequences via impairment in reflex and sensory 
functions, along with neuropsychiatric state [32]. As the 
disease progressed, multiple parameters became signifi-
cantly different in mice suffering from experimental cer-
ebral malaria versus non-cerebral control mice, which 
also correlated with mean size of brain haemorrhage 
[32]. In the present study of animal behaviour during P. 
chabaudi infection of IL-10−/− mice, an association of 
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Fig. 2 Brains from IL-10−/− animals show increased CD11b+ immune cell trafficking and MHC-II upregulation during Plasmodium chabaudi infec-
tion. Compiled from multiple independent experiments, cells were isolated from PBS-perfused brains of female IL-10−/− (KO) and C57Bl/6J (WT) 
mice 7–9 days post-infection (a) Representative FACS plots showing CD11b+CD45hi immune cells in the brain expressing Ly6C and MHC-II. b Total 
percent and number of Ly6C−MHC-II+ tissue macrophages and of Ly6C+MHC-II+ inflammatory monocytes within the CD11b+CD45hi gate. c Histo-
gram and % positive proportion of MHC-II expression and on CD45hiCD11b+ immune cells. Histogram colors Uninfected WT (Grey); day 7 and day 9 












Fig. 3 Brains from IL-10−/− animals show increased microglia activa-
tion during Plasmodium chabaudi infection. Compiled from multiple 
independent experiments, cells were isolated from PBS-perfused 
brains of female IL-10−/− (KO) and C57Bl/6J (WT) mice 7–9 days post-
infection. Mean fluorescent intensity (MFI) and histogram of MHC-II 
expression on resident microglia cells (CD11b+CD45int). Histogram 
colors Uninfected WT (Grey); day 7 and day 9 post-infection WT 
(Blue); day 7–9 post-infection IL-10−/− (Red). I infected, U uninfected. 
Student’s t test *p < 0.05, **p < 0.01
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main finding here was that at the peak of illness, wildtype 
animals performed better on virtually all behavioural 
tests than the IL-10−/− mice 24  h prior to death. Thus, 
deficiencies in functional behaviour domains may serve 
as early indicators of severe disease as some of these cat-
egories were decreased even earlier than 48  h prior to 
death (Table  1). The behavioural findings in this study 
are very similar to findings in P. berghei ANKA infection 
[32], suggesting brain involvement in the lethal pathology 
of P. chabaudi-infected IL-10−/− mice. Using this model, 
Brugat et al. have also shown indications of pathology in 
the liver and lungs, with concomitant sequestration in 
these organs. In addition, kidney pathology is present, 
however, there is no evidence of sequestration in the 
kidney, suggesting sequestration is not always the pri-
mary cause of organ pathology in this model [8]. Infected 
IL-10−/− mice show an increase in diagnostic markers 
of kidney damage and leukocyte trafficking to the lungs. 
These indications are seen in cases of multiple organ 
failure caused by severe malaria infection [38–40]. Liver 














































































































Fig. 4 Mice have IFN-γ-producing T cells in the brain during Plasmodium chabaudi infection. Compiled from two independent experiments, cells 
were isolated from PBS-perfused brains of female IL-10−/− (KO) and C57Bl/6J (WT) mice 7–9 days post-infection. a Representative FACS plots 
showing CD11b−CD45hi immune cells in the brain, gated on the Thy1.2+ population, then CD4 and CD8a. b Total cell numbers of CD4 and CD8 T 
cells within the CD11b−CD45hi/Thy1.2+/CD4+ or CD11b−CD45hi/Thy1.2+/CD8+ gate, respectively. c Histograms showing the expression of IFN-y in 
CD4+ and CD8+ T cells. Right panel MFI of IFN-y-expressing T cells in infected mice and uninfected controls. Percent positive proportion of infected 



























Fig. 5 CD4+ T cells exhibit intravascular localization in IL-10−/− ani-
mals infected with P. chabaudi. A 30 μm sagittal section of a female 
IL-10−/− (KO) brain 8 days post-inoculation with 105 Pcc-iRBCs i.p. 
Animals were injected with 2 × 106 CTV+ CD4 T cells i.p. 3.5 h before 
sacrifice, and 40 μg of DyLight488 labelled Lycopersicon esculentum 
(Tomato) Lectin i.v. 20 min before sacrifice without perfusion. Left 
panel Confocal image of an adoptively transferred CTV+ CD4+ T 
cell located in the Lectin+ microvasculature of the KO brain. Right 
panel Quantitation of adoptively transferred CTV+ CD4 T cells found 
inside or outside Lectin+ blood vessels within the KO brain. Imaging 
performed using a 20× objective with 4× digital zoom to visualize 
individual T cells within microvasculature
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mouse strain DBA/2 [41], which is mirrored in BALB/c 
mice lacking expression of haemoxygenase-1 (HO-1, 
Hmox1−/−) [42], a free haem-catalyzing enzyme under 
the regulation of IL-10 that has been shown to be impor-
tant in the pathogenesis of ECM and human CM [43, 44]. 
The role HO-1 plays in the pathogenesis of severe malaria 
in IL-10−/− mice infected with P. chabaudi has yet to be 
studied. While there are similarities between this model 
and ECM, the exact cause of death in IL-10−/− mice is 
unclear. Therefore, it is important that these findings 
demonstrate a significant peripheral immune infiltration 
of the central nervous system (CNS) vasculature, corre-
lating with neurological and behavioural deficits. Given 
the lack of correlation of sequestration with all organ 
damage, and given that the mortality of infected IL-10−/− 
mice can be prevented with neutralization of TNF [10, 
41], symptoms in this model are likely attributable to 
inflammation versus other features downstream of para-
site biomass.
Plasmodium chabaudi infection in IL-10−/− mice 
results in vascular leakage and haemorrhage [7], which 
is also observed in P. berghei ANKA infection [45]. This 
pathological finding has been linked to the accumula-
tion of cytotoxic CD8+ T cells in the cerebral micro-
vasculature [21, 23]. The presence of microvascular 
haemorrhages and cerebral oedema in human CM cases 
is correlated with adverse outcomes and death [3, 4]. The 
trafficking of pathogenic T cells and their involvement in 
mediating ECM is pertinent in our model, as it has been 
shown that selective deletion of IL-10 from T cells reca-
pitulates the fatal phenotype observed in IL-10−/− mice 
[27]. However, it is not known at what anatomical sites 
these cells are lethal. Non-Treg IFN-γ+ CD4+ T cells 
were identified as the primary producers of IL-10 in that 
study, as well as in lethal P. yoelii infection [46].
In order to characterize the cellular infiltrate, cell 
populations in the perfused brain tissue of P. chabaudi-
infected IL-10−/− mice were identified by flow cytometry. 
Significant increases in macrophages (CD45+CD11bhi) 
of two distinct types were observed in IL-10−/− animals 
compared to infection-matched WT animals. Inflamma-
tory monocytes (CD11b+Ly6C+) were identified as well 
as tissue-resident (CD11b+Ly6C−) macrophages, though 
these are also likely to include maturing infiltrating cells 
[47]. A significant increase in activation of microglia was 
also measured, suggesting that either cytokines, or con-
tact with other activated cell types, are affecting glial 
cells, which are an integral part of the brain parenchyma 
and act as the first line of defense in the CNS.
In this study, CD4+ T cells were found in perfused brains, 
suggesting that they are either adherent or have infiltrated 
into the brain parenchyma. We further show by confocal 
microscopy that they are located within the brain vascula-
ture of infected IL-10−/− mice. T cells in the brain were also 
shown to make IFN-γ, clearly demonstrating that patho-
logic lymphocytes traffic to the brain vasculature where 
they could contribute to the decrease in functional behav-
iour witnessed in IL-10−/− mice infected with P. chabaudi. 
Furthermore, this suggests that infiltration of pathological 
immune cells may not be necessary to affect neurologi-
cal function. Further supporting this interpretation, mice 
infected with the mild parasite Plasmodium chabaudi 
adami also transiently demonstrated behavioural defects, 
generalized microglial activation, and decreased neuro-
genesis despite the absence of gross cerebral vascular leak-
age [48]. Additionally, P. chabaudi adami-infected animals 
displayed elevated levels of pro-inflammatory cytokines in 
brain tissue during the peak of infection (day 9 post-infec-
tion), which resolved during the recovery phase (day 15 
post-infection) [48]. These data, together with the present 
study, suggest that while relatively mild levels of inflam-
mation may result in transiently altered behaviour, a cer-
tain threshold is required to enact irreparable damage and 
eventual death.
Conclusions
Infection of IL-10−/− mice with P. chabaudi induces a 
fatal malarial disease characterized by increased mortal-
ity, severe neurological and behavioural deficits, elevated 
numbers of IFN-γ+ T cells and macrophages adherent 
within the brain vasculature, and activated microglia, 
suggestive of elevated neuroinflammation. This study 
adds to the growing knowledge suggesting an integral 
role of inflammation in neuronal damage and down-
stream behavioural effects observed in malaria infection. 
These findings contribute to the current understanding 
of the aetiologies of cerebral pathology and neurocogni-
tive deficiencies in malaria infection.
Additional file
Additional file 1. Female IL-10−/− animals succumb to Plasmodium 
chabaudi infection and exhibit increased malaria-related pathology. A 
Survival of female and male IL-10−/− mice (KO) and female C57Bl/6 J mice 
(WT) inoculated with 105 Pcc-iRBCs i.p. and followed for 16 days during 
the acute phase of infection. Statistical significance determined by Log-
rank (Mantel-Cox) Test. B Animal weights (in grams) were measured dur-
ing the peak of infection via digital scale. Percent change in weight deter-
mined as compared to baseline measurement (2 days pre-inoculation). 
Student’s t test ***p < 0.001. C Infection-matched female IL-10−/− and WT 
animals were implanted with subdermal temperature-transmitting micro-
chips and monitored daily throughout the peak of infection. Student’s t 
test **p < 0.01, ***p < 0.001. D Slides of thin blood smears from the tail 
vein were collected and stained to measure peripheral parasitaemia. Data 
points and error bars represent mean values and ± SEM, respectively.
Page 11 of 12Wilson et al. Malar J  (2016) 15:428 
Abbreviations
CM: cerebral malaria; IL-10−/−: IL-10-deficient; WT: wild-type, C57Bl/6J; SHIRPA: 
SmithKline Beecham, Harwell, Imperial College, Royal London Hospital, phe-
notype assessment; ECM: experimental cerebral malaria; iRBCs: infected red 
blood cells; i.p.: intraperitoneal; ICAM-1: intracellular adhesion molecule-1; IFN-
γ: interferon gamma; TNF: tumour necrosis factor; MHC-II: major histocompat-
ibility complex class II; CXCR3: C-X chemokine receptor 3; CNS: central nervous 
system; PBS: phosphate-buffered saline; SEM: standard error of the mean; SD: 
standard deviation; FBS: fetal bovine serum; ANOVA: analysis of variance; PMA: 
phorbol 12-myristate 13-acetate.
Authors’ contributions
Animal behaviour studies were designed by KTD and RS, conducted by KDW 
with assistance from SJS, and analysed by KDW, RS, KTD, and SJS. Fluorescent 
imaging studies were designed by GV and RS, conducted by KDW, and ana-
lysed by KDW, LFO, GV, and RS. Flow cytometry studies were designed by PCC 
and RS, conducted by KDW with assistance from GAV, and analysed by KDW 
and RS. Statistical analyses, tables, and figures generated by KDW. KDW and RS 
drafted the manuscript, with important input from KTD, GV, PCC, and GAV. All 
authors read and approved the final manuscript.
Author details
1 Department of Microbiology and Immunology, University of Texas Medical 
Branch, 301 University Blvd., Galveston, TX 77555, USA. 2 Mitchell Center 
for Neurodegenerative Diseases, Center for Addiction Research, University 
of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. 
3 Center for Biomedical Engineering, University of Texas Medical Branch, 
301 University Blvd., Galveston, TX 77555, USA. 4 Department of Pathology, 
University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, 
USA. 5 Department of Internal Medicine, Division of Infectious Diseases, Uni-
versity of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. 
6 Department of Neurology, University of Texas Medical Branch, 301 University 
Blvd., Galveston, TX 77555, USA. 7 Department of Neuroscience and Cell Biol-
ogy, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 
77555, USA. 8 Institute for Human Infections and Immunity, University of Texas 
Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. 
Acknowledgements
We would like to acknowledge Jiaren Sun for reagents, Yongquan Jiang for 
technical assistance in confocal microscopy, and Ping Wu and Tiffany Dunn 
for assistance with preparation of frozen tissue sections. We appreciate 
feedback from the UTMB Joint Immunology Lab Meeting and the Neuro-
Infectious Diseases working group, including Kathryn Cunningham. We also 
are grateful for excellent animal care by Margarita Ramirez.
Competing interests
The authors declare that they have no competing interests.
Availability of data and material
All data generated or analysed during this study are included in this published 
article and its supplementary information files.
Ethics approval and consent to participate
Animals were cared for according to the Guide for the Care and Use of 
Laboratory Animals under the Institutional Animal Care and Use Committee-
approved protocol #1006031. UTMB Animal Resource Center facilities operate 
in compliance with the USDA Animal Welfare Act, the Guide for the Care and 
Use of Laboratory Animals, under OLAW accreditation, and IACUC-approved 
protocols.
Funding
This study was supported by the University of Texas Medical Branch Institute 
for Human Infection and Immunity (RS, KDW), McLaughlin Endowment Pre-
doctoral Grant (KDW), and the U.S. National Institutes of Health [R01AI363327 
(RS), T32AI363327 (KDW)]. This study was also funded by a University of Texas 
System Neuroscience and Neurotechnology Research Institute UT BRAIN Seed 
Grant (RS, #363327).
Received: 11 April 2016   Accepted: 10 August 2016
References
 1. WHO. World Malaria Report 2015. Geneva: World Health Organiza-
tion; 2015. http://www.who.int/malaria/publications/world-malaria-
report-2015/en/. Accessed 07 Apr 2016.
 2. Amante FH, Haque A, Stanley AC, de Rivera F, Randall LM, Wilson YA, et al. 
Immune-mediated mechanisms of parasite tissue sequestration during 
experimental cerebral malaria. J Immunol. 2010;185:3632–42.
 3. Seydel KB, Kampondeni SD, Valim C, Potchen MJ, Milner DA, Muwalo FW, 
et al. Brain swelling and death in children with cerebral malaria. N Engl J 
Med. 2015;372:1126–37.
 4. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JG, Fosiko NG, et al. Dif-
ferentiating the pathologies of cerebral malaria by postmortem parasite 
counts. Nat Med. 2004;10:143–5.
 5. Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, et al. 
Haplotypes of IL-10 promoter variants are associated with susceptibility 
to severe malarial anemia and functional changes in IL-10 production. 
Hum Genet. 2008;124:515–24.
 6. May J, Lell B, Luty AJ, Meyer CG, Kremsner PG. Plasma interleukin-10: 
tumor necrosis factor (TNF)-alpha ratio is associated with TNF pro-
moter variants and predicts malarial complications. J Infect Dis. 
2000;182:1570–3.
 7. Sanni LA, Jarra W, Li C, Langhorne J. Cerebral edema and cerebral 
hemorrhages in interleukin-10-deficient mice infected with Plasmodium 
chabaudi. Infect Immun. 2004;72:3054–8.
 8. Brugat T, Cunningham D, Sodenkamp J, Coomes S, Wilson M, Spence PJ, 
et al. Sequestration and histopathology in Plasmodium chabaudi malaria 
are influenced by the immune response in an organ-specific manner. Cell 
Microbiol. 2014;16:687–700.
 9. Mota MM, Jarra W, Hirst E, Patnaik PK, Holder AA. Plasmodium 
chabaudi-infected erythrocytes adhere to CD36 and bind to micro-
vascular endothelial cells in an organ-specific way. Infect Immun. 
2000;68:4135–44.
 10. Li C, Sanni LA, Omer F, Riley E, Langhorne J. Pathology of Plasmodium 
chabaudi chabaudi infection and mortality in interleukin-10-deficient 
mice are ameliorated by anti-tumor necrosis factor alpha and exacer-
bated by anti-transforming growth factor beta antibodies. Infect Immun. 
2003;71:4850–6.
 11. Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anae-
mia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br 
J Haematol. 1988;70:99–103.
 12. Mastelic B, do Rosario AP, Veldhoen M, Renauld JC, Jarra W, Sponaas AM, 
et al. IL-22 protects against liver pathology and lethality of an experimen-
tal blood-stage malaria infection. Front Immunol. 2012;3:85.
 13. Findlay EG, Greig R, Stumhofer JS, Hafalla JCR, de Souza JB, Saris CJ, 
et al. Essential role for IL-27 receptor signaling in prevention of Th1-
mediated immunopathology during malaria infection. J Immunol. 
2010;185:2482–92.
 14. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, et al. 
Parasite antigen-specific interleukin-10 and antibody reponses predict 
accelerated parasite clearance in Plasmodium falciparum malaria. Eur 
Cytokine Netw. 1998;9:639–46.
 15. Milner DA Jr, Whitten RO, Kamiza S, Carr R, Liomba G, Dzamalala C, et al. 
The systemic pathology of cerebral malaria in African children. Front Cell 
Infect Microbiol. 2014;4:104.
 16. Manning L, Rosanas-Urgell A, Laman M, Edoni H, McLean C, Mueller I, 
et al. A histopathologic study of fatal paediatric cerebral malaria caused 
by mixed Plasmodium falciparum/Plasmodium vivax infections. Malar J. 
2012;11:107.
 17. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, et al. 
The neuropathology of fatal cerebral malaria in malawian children. Am J 
Pathol. 2011;178:2146–58.
 18. Berendt A, Tumer G, Newbold C. Cerebral malaria: the sequestration 
hypothesis. Parasitol Today. 1994;10:412–4.
 19. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice 
LA, et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 
are required for the development of murine cerebral malaria. Proc Natl 
Acad Sci USA. 2008;105:4814–9.
 20. Rudin W, Eugster HP, Bordmann G, Bonato J, Müller M, Yamage M, et al. 
Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-
deficient mice is associated with a reduction of intercellular adhesion 
Page 12 of 12Wilson et al. Malar J  (2016) 15:428 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
molecule-1 up-regulation and T helper type 1 response. Am J Pathol. 
1997;150:257–66.
 21. Belnoue E, Kayibanda M, Vigario AM, Deschemin J-C, Nv Rooijen, Viguier 
M, et al. On the pathogenic role of brain-sequestered αβ CD8 + T cells in 
experimental cerebral malaria. J Immunol. 2002;169:6369–75.
 22. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, 
et al. Perforin-dependent brain-infiltrating cytotoxic CD8 + T lympho-
cytes mediate experimental cerebral malaria pathogenesis. J Immunol. 
2003;170:2221–8.
 23. Potter S, Chan-Ling T, Ball HJ, Mansour H, Mitchell A, Maluish L, et al. 
Perforin mediated apoptosis of cerebral microvascular endothelial cells 
during experimental cerebral malaria. Int J Parasitol. 2006;36:485–96.
 24. Belnoue E, Potter SM, Rosa DS, Mauduit M, Grüner AC, Kayibanda M, et al. 
Control of pathogenic CD8 + T cell migration to the brain by IFN-γ dur-
ing experimental cerebral malaria. Parasite Immunol. 2008;30:544–53.
 25. Linke A, Kühn R, Müller W, Honarvar N, Li C, Langhorne J. Plasmodium 
chabaudi chabaudi: differential susceptibility of gene-targeted mice 
deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol. 
1996;84:253–63.
 26. Li C, Corraliza I, Langhorne J. A Defect in interleukin-10 leads to enhanced 
malarial disease in Plasmodium chabaudi chabaudi infection in mice. 
Infect Immun. 1999;67:4435–42.
 27. do Freitas Rosario AP, Lamb T, Spence P, Stephens R, Lang A, Roers A, et al. 
IL-27 promotes IL-10 production by effector Th1 CD4 + T cells: a critical 
mechanism for protection from severe immunopathology during malaria 
infection. J Immunol. 2012;188:1178–90.
 28. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. Behavioral 
and functional analysis of mouse phenotype: SHIRPA, a proposed 
protocol for comprehensive phenotype assessment. Mamm Genome. 
1997;8:711–3.
 29. Yap GS, Stevenson MM. Plasmodium chabaudi AS: erythropoietic 
responses during infection in resistant and susceptible mice. Exp Parasi-
tol. 1992;75:340–52.
 30. Cross CE, Langhorne J. Plasmodium chabaudi chabaudi (AS): inflammatory 
cytokines and pathology in an erythrocytic-stage infection in mice. Exp 
Parasitol. 1998;90:220–9.
 31. Lamb TJ, Langhorne J. The severity of malarial anaemia in Plasmodium 
chabaudi infections of BALB/c mice is determined independently of the 
number of circulating parasites. Malar J. 2008;7:68.
 32. Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, et al. Behav-
ioural and histopathological alterations in mice with cerebral malaria. 
Neuropathol Appl Neurobiol. 2006;32:177–88.
 33. Desruisseaux MS, Gulinello M, Smith DN, Lee SC, Tsuji M, Weiss LM, et al. 
Cognitive dysfunction in mice infected with Plasmodium berghei strain 
ANKA. J Infect Dis. 2008;197:1621–7.
 34. Hermsen C, Van De Wiel T, Mommers E, Sauerwein R, Eling W. Depletion 
of CD4+ or CD8 + T-cells prevents Plasmodium berghei induced cerebral 
malaria in end-stage disease. Parasitology. 1997;114:7–12.
 35. Poh CM, Howland SW, Grotenbreg GM, Renia L. Damage to the blood-
brain barrier during experimental cerebral malaria results from synergistic 
effects of CD8 + T cells with different specificities. Infect Immun. 
2014;82:4854–64.
 36. Villegas-Mendez A, Greig R, Shaw TN, de Souza JB, Gwyer Findlay E, Stum-
hofer JS, et al. IFN-gamma-producing CD4 + T cells promote experimen-
tal cerebral malaria by modulating CD8 + T cell accumulation within the 
brain. J Immunol. 2012;189:968–79.
 37. Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Miranda AS, Amaral DC, 
Camargos ER, et al. Inflammatory changes in the central nervous system 
are associated with behavioral impairment in Plasmodium berghei (strain 
ANKA)-infected mice. Exp Parasitol. 2010;125:271–8.
 38. Trang TTM, Phu NH, Vinh H, Hien TT, Cuong BM, Chau TTH, et al. Acute 
renal failure in patients with severe falciparum malaria. Clin Infect Dis. 
1992;15:874–80.
 39. Mohan A, Sharma SK, Bollineni S. Acute lung injury and acute respiratory 
distress syndrome in malaria. J Vector Borne Dis. 2008;45:179–93.
 40. Krishnan A, Karnad DR. Severe falciparum malaria: an important cause of 
multiple organ failure in Indian intensive care unit patients. Crit Care Med. 
2003;31:2278–84.
 41. Seixas E, Oliveira P, Moura Nunes JF, Coutinho A. An experimental model 
for fatal malaria due to TNF-α-dependent hepatic damage. Parasitology. 
2008;135:683–90.
 42. Seixas E, Gozzelino R, Chora Â, Ferreira A, Silva G, Larsen R, et al. Heme 
oxygenase-1 affords protection against noncerebral forms of severe 
malaria. Proc Natl Acad Sci USA. 2009;106:15837–42.
 43. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, et al. Heme 
oxygenase-1 and carbon monoxide suppress the pathogenesis of experi-
mental cerebral malaria. Nat Med. 2007;13:703–10.
 44. Clark IA, Awburn MM, Harper CG, Liomba NG, Molyneux ME. Induction of 
HO-1 in tissue macrophages and monocytes in fatal falciparum malaria 
and sepsis. Malar J. 2003;2:41.
 45. Neill AL, Hunt NH. Pathology of fatal and resolving Plasmodium berghei 
cerebral malaria in mice. Parasitology. 1992;105:165–75.
 46. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, Kamanaka M, et al. 
IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates 
parasite clearance and pathology during malaria infection. PLoS Pathog. 
2008;4:e1000004.
 47. Sponaas A-M, do Freitas Rosario AP, Voisine C, Mastelic B, Thomp-
son J, Koernig S, et al. Migrating monocytes recruited to the spleen 
play an important role in control of blood stage malaria. Blood. 
2009;114:5522–31.
 48. Guha SK, Tillu R, Sood A, Patgaonkar M, Nanavaty IN, Sengupta A, et al. 
Single episode of mild murine malaria induces neuroinflammation, alters 
microglial profile, impairs adult neurogenesis, and causes deficits in social 
and anxiety-like behavior. Brain Behav Immun. 2014;42:123–37.
